Aeterna Zentaris Inc., of Quebec City, appointed David A. Dodd president and CEO...Igenica Inc., of Burlingame, Calif., appointed Thi-Sau Migone chief scientific officer

Bristol-Myers Squibb Co., of New York, named Francis Cuss executive vice president and chief scientific officer, effective July 1...EntreMed Inc., of Rockville, Md., appointed Ken K. Ren CEO, and added James Huang and Y. Alexander Wu to its board

Caris Life Sciences Inc., of Irving, Texas, appointed Joachim Schorr chief scientific officer...Champions Oncology Inc., of Hackensack, N.J., added Dan Mendelson and Arthur G

Ironwood Pharmaceuticals Inc., of Cambridge, Mass., named Mark Currie senior vice president, chief scientific officer and president of research and development...Mylan Inc., of Pittsburgh, added Melina Higgins and Rajiv Malik to its board

Esperion Therapeutics Inc., of Plymouth, Mich., named Tim Mayleben president and CEO and Roger Newton executive chairman and chief scientific officer...plc, of Dublin, Ireland, added Richard T. Colllier and Shane Cooke to its board

DART Therapeutics LLC, of Cambridge, Mass., named Eugene W. Williams CEO, Ernest D. Bush chief scientific officer, Elliot Goldstein chief medical officer and Cabot Brown chief financial officer...Fedora Pharmaceuticals Inc., of Edmonton, Alberta, appointed Thomas Parr chief scientific officer...Islet Sciences Inc., of New York, added Kevan Herold and Morton Printz to its scientific advisory board

Alexza Pharmaceuticals Inc., of Mountain View, Calif., named James Cassella executive vice president, research and development and chief scientific officer...Mark Oki senior vice president, finance and chief financial officer

ADMA Biologics Inc., of Hackensack, N.J., appointed James Mond chief medical and scientific officer and added Lawrence Guiheen to its board...Curemark LLC, of Rye, N.Y., named Matthew Heil chief scientific officer and James Szigethy vice president of research and product development

Addex Therapeutics Ltd., of Geneva, named Graham Dixon chief scientific officer and head of research...and Thomas Rollins senior vice president of program and portfolio management

Oncothyreon Inc., of Seattle, appointed Scott Peterson chief scientific officer...Saladax Biomedical Inc., of Bethlehem, Pa., named Kevin Harter president and CEO

Ember Therapeutics Inc., of Boston, named Jasbir Seehra chief scientific officer and Jeff Saunders vice president, small-molecule drug discovery...Paratek Pharmaceuticals Inc., of Boston, appointed Dennis Molnar CEO and director and Evan Loh chief medical officer and board chairman

NeurOp Inc., of Atlanta, appointed Robert Zaczek chief scientific officer...Northwest Biotherapeutics, of Bethesda, Md., added Navid Malik and Jerry Jasinowski to its board

Adventrx Pharmaceuticals Inc., of San Diego, formed a regulatory advisory board (RAB) and appointed Cindy Dinella and Bonnie Hepburn to the RAB, with Frank Sasinowski as RAB advisor...Bellicum Pharmaceuticals Inc., of Houston, named David Spencer chief scientific officer

and Christine Mikail, executive vice president, corporate development, general counsel and secretary...Permeon Biologics, of Cambridge, Mass., appointed Katherine Bowdish president and chief scientific officer

PaxVax Corp., of Menlo Park, Calif., appointed Nima Farzan executive vice president and chief operating officer, Thomas P. Monath chief technology officer and Jonathan F. Smith executive vice president and chief scientific officer...Tris Pharma, of Monmouth Junction, N.J., named Mahdi Fawzi chief scientific officer and executive vice president of R&D

Ablynx NV, of Ghent, Belgium, appointed Andreas Menrad chief scientific officer...Rusty" Williams president and CEO and named Brian Atwood chairman

Ablynx NV, of Ghent, Belgium, appointed Andreas Menrad chief scientific officer...Acella Pharmaceuticals Inc., of Atlanta, appointed Allen Fields vice president and head of R&D

It also added John E. Dick and Janet Rossant to its scientific and clinical advisory board...Zyngenia Inc., of Gaithersburg, Md., promoted David M. Hilbert to chief scientific officer and named Daniel L. Menichella chief business officer

It also appointed Lex Van der Ploeg chief scientific officer...SAGE Therapeutics Inc., of Boston, appointed Albert J. Robichaud chief scientific officer and named Jean-Cosme Dodart director of pharmacology